We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

18 hedge funds and large institutions have $812K invested in Bio-Path Holdings Inc in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $793K → $812K (+$19K)

14% less funds holding

Funds holding: 21 → 18 (-3)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$18.4K
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.7K

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$104K
2
Citadel Advisors
Citadel Advisors
Florida
-$49.3K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$19K
4
UBS Group
UBS Group
Switzerland
-$2.62K
5
TRCT
Tower Research Capital (TRC)
New York
-$895
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$426K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$119K – – –
BlackRock
3
BlackRock
New York
$86.3K – – –
MYIA
4
Mount Yale Investment Advisors
Colorado
$45.1K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$38K +$1.7K +55 +5%
Northern Trust
6
Northern Trust
Illinois
$31.5K – – –
State Street
7
State Street
Massachusetts
$23.1K – – –
VF
8
Virtu Financial
New York
$21K +$18.4K +596 New
TRCT
9
Tower Research Capital (TRC)
New York
$10.5K -$895 -29 -9%
Bank of America
10
Bank of America
North Carolina
$5.8K – – –
Group One Trading
11
Group One Trading
Illinois
$3.54K – – –
Morgan Stanley
12
Morgan Stanley
New York
$1.25K – – –
JP Morgan Chase
13
JP Morgan Chase
New York
$766 -$31 -1 -4%
CA
14
Crewe Advisors
Utah
$125 – – –
GRP
15
Global Retirement Partners
California
$123 – – –
Wells Fargo
16
Wells Fargo
California
$101 – – –
Osaic Holdings
17
Osaic Holdings
Arizona
$18 – – –
Walleye Capital
18
Walleye Capital
New York
– -$104K -3,751 Closed
Citadel Advisors
19
Citadel Advisors
Florida
– -$49.3K -1,773 Closed
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
– -$19K -683 Closed
UBS Group
21
UBS Group
Switzerland
– -$2.62K -94 Closed

BPTH Hedge Fund Activity: Q2 2023 in Review

18 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2023, worth a combined $812K — up 2.4% from $793K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BPTH and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $18.4K. The largest seller was Walleye Capital, exiting entirely with an estimated $104K sold.

  • 18 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2023, down from 21 in Q1 2023.
  • Funds reported $812K of Bio-Path Holdings Inc stock for Q2 2023, up 2.4% quarter-over-quarter.
  • 1 fund opened new Bio-Path Holdings Inc positions in Q2 2023 and 4 closed out, a net change of -3 holders.
  • The largest Bio-Path Holdings Inc buyer in Q2 2023 was Virtu Financial, an estimated $18.4K added.
  • The largest Bio-Path Holdings Inc seller in Q2 2023 was Walleye Capital, an estimated $104K sold.

Based on aggregated 13F filings for Q2 2023.